In December 2012, a 76-year-old woman with a history of hypertension underwent coronary
angiography for ST-segment elevation myocardial infarction. A subocclusive lesion in the …

Introduction Emergency revascularisation by primary percutaneous coronary intervention
(PCI) is the preferred strategy for patients presenting with ST-elevation myocardial infarction …

Objectives To investigate one-year outcomes after implantation of a bioresorbable vascular
scaffold (BVS) in patients presenting with acute coronary syndrome (ACS) compared to …

Objectives: The aim of this study was to assess the feasibility and clinical results following a
pre-specified bioresorbable scaffold (Absorb BVS) implantation strategy in patients with ST …

Background Primary percutaneous coronary intervention with implantation of a metallic drug-
eluting stent (DES) is the standard treatment for patients presenting with ST-elevation …

Background: The term acute coronary syndrome (ACS) refers to any group of clinical
symptoms compatible with acute myocardial ischemia. These high-risk manifestations of …

Background The Fantom sirolimus-eluting bioresorbable scaffold (BRS)(REVA Medical)
incorporates a unique polycarbonate copolymer of tyrosine analogues characterized by a …

Aims Patients with ST-segment elevation myocardial infarction (STEMI) feature thrombus-
rich lesions with large necrotic core, which are usually associated with delayed arterial …

Aims: The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical
outcomes compared with a durable polymer-based everolimus-eluting metallic stent (EES) …

This editorial refers to 'Prospective, randomized trial of bioresorbable scaffolds vs.
everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction …